IL36G and neoplasm: Consistently, the tumor development in the lungs of KL or KP mice and the Ki67+ staining in the lung tumors were substantially inhibited by anti‐IL‐36γ treatment (Figure 7C–F), indicating that neutralizing IL‐36γ inhibits NSCLC progression.